Search Count: 7
 |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: 4T9, 1PE, 7PE |
 |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.36 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: 7PE, 7CE, EDO |
 |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: 7RO, 7PE, EDO |
 |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: 7RO, 7PE |
 |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: X20, 7PE |
 |
Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2013-12-04 Classification: TRANSFERASE Ligands: X21 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2013-03-13 Classification: TRANSFERASE Ligands: VEK, SO4 |